Artigo Revisado por pares

Prioritising snakebite in the child and adolescent health agenda

2023; Elsevier BV; Volume: 7; Issue: 11 Linguagem: Inglês

10.1016/s2352-4642(23)00224-9

ISSN

2352-4650

Autores

Soumyadeep Bhaumik, Geetha Menon, Abdulrazaq G. Habib,

Tópico(s)

Healthcare and Venom Research

Resumo

In recognition of its public health burden, WHO designated snakebite envenoming (the clinical condition caused by the effects of venom from a venomous snake on a human being) as a neglected tropical disease (NTD) in 2017. 1 Williams DJ Faiz MA Abela-Ridder B et al. Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl Trop Dis. 2019; 13e0007059 Crossref Scopus (237) Google Scholar It is estimated that almost 80% of all deaths caused by snakebite occur in south Asia and sub-Saharan Africa, where snakebite primarily affects rural, agricultural, and indigenous communities. Moreover, children, adolescents, and young adults in these regions are the populations most affected by snakebite. 15 years ago, the 2008 World Child Injury Report already recognised snakebite as an important cause of death in children, yet it continues to be neglected by the global child and adolescent health community. 2 Roberts NLS Johnson EK Zeng SM et al. Global mortality of snakebite envenoming between 1990 and 2019. Nature Communications. 2022; 136160 Google Scholar

Referência(s)